BRIEF published on 05/21/2024 at 17:25, 7 months ago Methapharm Announces Partnership With Bosch FDA Respiratory Diagnostics Methapharm Bosch Vivatmo Pro
BRIEF published on 05/21/2024 at 17:25, 7 months ago Methapharm annonce un partenariat avec Bosch FDA Diagnostic Respiratoire Bosch Vivatmo Pro Méthapharma
PRESS RELEASE published on 05/21/2024 at 17:20, 7 months ago Methapharm Announces Partnership With Bosch Methapharm Respiratory partners with Bosch Health Solutions to distribute FDA-cleared FeNO device, Vivatmo Pro, in the U.S. Enhancing respiratory diagnostics with innovative technology Respiratory Diagnostics FDA-cleared Vivatmo Pro Methapharm Respiratory Bosch Health Solutions
Published on 12/21/2024 at 01:30, 18 hours ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 25 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 20 hours ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 18 hours 39 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 45 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 18:00, 1 day 1 hour ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 7 hours 13 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 13 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
